Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$956M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$924M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$769M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$410M |
| 5 |
Kenvue
KVUE
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$411M |
| 2 |
Johnson & Johnson
JNJ
|
+$234M |
| 3 |
Cisco
CSCO
|
+$181M |
| 4 |
iShares Gold Trust
IAU
|
+$143M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.03% |
| 2 | Healthcare | 12.31% |
| 3 | Financials | 11.79% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Velocity Financial
VEL
$689M
| $319K | ﹤0.01% |
28,217
| – | – |
|
3202
Empire Petroleum
EP
$99.1M
| $317K | ﹤0.01% |
32,913
+6,081
| +23% | +$54.7K |
|
3203
ClearPoint Neuro
CLPT
$448M
| $314K | ﹤0.01% |
62,770
| – | – |
|
3204
Mayville Engineering Co
MEC
$654M
| $313K | ﹤0.01% |
28,577
| – | – |
|
3205
Fennec Pharmaceuticals
FENC
$332M
| $312K | ﹤0.01% |
41,497
| – | – |
|
3206
USCB Financial Holdings
USCB
$406M
| $310K | ﹤0.01% |
29,478
| – | – |
|
|
CARM
3207
DELISTED
Carisma Therapeutics
CARM
| $308K | ﹤0.01% |
72,743
| – | – |
|
3208
Smartbird Inc
BIRD
$19.5M
| $306K | ﹤0.01% |
13,797
+957
| +7% | +$25.8K |
|
3209
Tenaya Therapeutics
TNYA
$161M
| $305K | ﹤0.01% |
119,532
| – | – |
|
|
CUTR
3210
DELISTED
Cutera, Inc.
CUTR
| $303K | ﹤0.01% |
50,338
+4,291
| +9% | +$54.4K |
|
|
IMA
3211
ImageneBio Inc
IMA
$63M
| $302K | ﹤0.01% |
5,811
+756
| +15% | +$45.5K |
|
3212
Inogen
INGN
$175M
| $302K | ﹤0.01% |
57,840
-102,293
| -64% | -$727K |
|
3213
Global Water Resources
GWRS
$206M
| $299K | ﹤0.01% |
30,651
| – | – |
|
3214
Mistras Group
MG
$484M
| $298K | ﹤0.01% |
54,631
| – | – |
|
3215
Mammoth Energy Services
TUSK
$128M
| $297K | ﹤0.01% |
63,981
| – | – |
|
3216
HEICO Corp Class A
HEI.A
$36B
| $296K | ﹤0.01% |
2,292
-268,001
| -99% | -$36.3M |
|
3217
Ezcorp Inc
EZPW
$1.83B
| $295K | ﹤0.01% |
35,753
-2,651
| -7% | -$22.8K |
|
|
NGM
3218
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $294K | ﹤0.01% |
275,064
+3,376
| +1% | +$6.99K |
|
3219
Century Therapeutics
IPSC
$364M
| $294K | ﹤0.01% |
146,801
-13,257
| -8% | -$35.3K |
|
3220
Annexon
ANNX
$834M
| $292K | ﹤0.01% |
123,668
| – | – |
|
3221
NI Holdings
NODK
$310M
| $292K | ﹤0.01% |
22,654
| – | – |
|
3222
Larimar Therapeutics
LRMR
$397M
| $291K | ﹤0.01% |
73,763
| – | – |
|
3223
Southland Holdings
SLND
$30.2M
| $290K | ﹤0.01% |
47,704
+5,035
| +12% | +$37.2K |
|
3224
Townsquare Media
TSQ
$106M
| $288K | ﹤0.01% |
33,058
| – | – |
|
|
BHIL
3225
DELISTED
Benson Hill, Inc.
BHIL
| $288K | ﹤0.01% |
24,834
-3,540
| -12% | -$110K |
|
Similar funds
Charles Schwab's Q3 2023 Portfolio in Review
As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.
- Charles Schwab's largest Q3 2023 buy was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
- Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
- Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
- Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
- Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
- Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
- Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.
Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.